ACTIVE HALF-LIFE
9 days
CLASSIFICATION
Psychoactive Antidepressants (SNDRI)
DOSAGE
0.25 mg - 1 mg
ACNE
None
WATER RETENTION
None
HBR
Possibly
HEPATOTOXICITY
Low Risk
AROMATIZATION
None
MANUFACTURER
Pharmacom Labs
WAREHOUSE
International Warehouse 3
SUBSTANCE
Tesofensine
,
Discover the power of **Tesofensine**, an innovative Triple Serotonin Norepinephrine Dopamine Reuptake Inhibitor (SNDRI) designed to elevate your mood and enhance your well-being. This psychoactive antidepressant is engineered to influence key neurotransmitters in the brain?serotonin, norepinephrine, and dopamine?resulting in a profound sense of satisfaction during meals while effectively suppressing appetite. Originally developed and patented by NeuroSearch A/S in Denmark for treating Parkinson's and Alzheimer's diseases, Tesofensine is a game-changer in appetite control and weight management.
- It targets the central nervous system, promoting appetite suppression, optimizing dopamine receptor availability, and activating ?1-adrenergic receptors.
- Experience noticeable appetite reduction within just 14 days, leading to increased feelings of fullness and a decreased desire to snack.
- Tesofensine significantly boosts fat oxidation and reduces adipose tissue levels.
- With improved insulin sensitivity, this powerful substance enhances glucose metabolism.
- It alters the expression and binding of dopaminergic receptors in the brain's striatum, optimizing brain function.
- Expect a significant rise in energy expenditure within 14 days of use.
- With a long half-life of 9 days, Tesofensine is primarily metabolized in the liver by CYP3A4 into the disalkyl metabolite M1 (NS-2360), which is the only detectable metabolite in human plasma.
CAUTION: The listed price is for one blister containing 50 pills. Please note that if you order only one blister, it will be shipped without the original packaging. To receive the original box, we recommend ordering two blisters (100 pills).